Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

CDC has approved spring COVID booster for some. Do you need it?

Another COVID-19 booster shot is on the way as federal health officials look to further augment protection for those at greater risk of developing severe disease.

Los Angeles Times

Extra spring COVID booster cleared for certain Americans

Certain Americans at high risk from COVID-19 can get an extra vaccine booster this spring

The Independent UK

Autumn Covid booster 2023: Who is eligible for another jab?

If invited, you will receive a booster dose of a Covid-19 vaccine made by Pfizer, Moderna, or Sanofi

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

Sanofi: the new protein-based Covid vaccine to be used in the UK

The University of Edinburgh’s Neil Mabbott on the vaccine technology being used for Covid booster jabs from this month.

The Week

5million people called on to get another Covid jab from today

Eligible people include those aged 75 and over, and anyone aged five and over who has a weakened immune system

Wales Online

Millions eligible for Covid jab as spring booster campaign begins

Around five million people in total are eligible for a booster until the end of June.

The Independent UK

Protect yourself from side effects just by reading this article

Research shows that knowing about the nocebo effect – the 'evil twin' of the placebo effect – means you are less likely to experience negative side effects of drugs or treatments, says Dr Kate MacKrill

Newsroom.co.nz

Read news from The Economist, FT, and more,
with one subscription

Everything we know about new Sanofi Covid vaccine now being used in UK

The vaccine being used in the Spring booster campaign works in a different way to previous jabs

Wales Online

Sanofi vaccine: what to know about this protein-based COVID booster being offered in the UK

In the UK a spring booster campaign has recently begun, offering an additional vaccine to people at highest risk from COVID. Between April and June 2023 people aged over 75, residents in care homes and children and adults aged five and up with weakened immune systems will be invited to…

The Conversation

Pregnant this winter? Here's how to prepare for COVID and get vaccinated

With the days becoming noticeably shorter, winter is on its way in the Southern Hemisphere.

The Conversation

Pharmaceutical executives challenge Texas court’s abortion pill ruling

Gilead Sciences and Pfizer join amicus brief

The Independent UK

300 biotech and pharma CEOs including the head of Pfizer call for a reversal of the abortion pill ban

Pfizer’s Albert Bourla is among the CEOs who signed a letter against suspending mifepristone, citing its impact on the FDA and the biotech industry.

Fortune

Vaccines for cancer could be ready by 2030, according to Moderna chief

The pharmaceutical firm said it is confident the jabs for cancer could be ready by the end of the decade

Manchester Evening News

‘Groundbreaking’ cancer and heart disease vaccine ‘could save millions of lives’

Experts hope new vaccines will be ready by end of decade

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Cancer and heart disease vaccines ‘ready by end of the decade’

Exclusive: Pharmaceutical firm says groundbreaking jabs could save millions of lives

Wales Online

Covid jab offered to some babies and children from the age of six months

The vaccine has been approved for use in children age between six months and four years old

StockNews.com

3 Low P/E Stocks Gearing Up to Rebound This Year

Recent banking turmoil and rising interest rates have weighed heavily on investors’ sentiment lately. However, weak economic data signaling slowing growth could result in relatively easy monetary policies in the second half of 2023. Given the macroeconomic backdrop, investors could consider adding fundamentally sound low P/E stocks Pfizer (PFE), Chevron…

The Independent UK

Babies and children under five to be offered Covid jab for the first time

The JCVI has advised that clinically vulnerable children aged six months to four years should be offered the vaccincation.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Covid vaccine to be offered to vulnerable babies and children in UK

Eligible children between six months and four years old will be offered jab from June

The Guardian - UK

Ursula von der Leyen: EU’s ‘general’ nears endgame of turbulent first term

European Commission president is praised for work ethic and response to Covid and Ukraine war, but some see her as aloof

Bangkok Post

Institute offers booster shots

The Institute of Dermatology is offering a Covid-19 vaccination service using the Gen2-Bivalent Pfizer vaccine at its headquarters on Ratchawithi Road.

The Independent UK

Covid booster jab rollout to begin for 5 million most vulnerable people

Cases are at their highest level since the start of the year, according to last ever ONS survey

The Guardian - UK

Covid booster vaccine to be offered to millions in England next week

Care home residents will be first to receive spring top-up jab as infections in England hit 2023 high

Wales Online

Spring Covid booster campaign set to launch next week

Around five million UK residents are eligible for the booster until the end of June

The Independent UK

Spring Covid booster campaign gets under way next week

Millions of people will be sent their initial invitations through the NHS app, where they can also book their appointment.

1 … 25 26 27 28

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

the University of Edinburgh

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

the Southern Hemisphere

44 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.